Deforolimus Trial 106-A Phase I Trial Evaluating 7 Regimes of Oral Deforolimus (AP23573, MK-8669)

Reviewer: Eric Shinohara MD, MSCI
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 31 de mayo del 2008

Translation for this article does not exist


Click on any of these terms for more related articles


Smoothies for All Occasions
by OncoLink Editorial Team
May 24, 2016